{"id":"NCT01918033","sponsor":"Organon and Co","briefTitle":"A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)","officialTitle":"A Phase III, Multi-Center, Randomized, Parallel-Group, Placebo-Controlled and Double- Blind Trial to Study the Efficacy and Safety of MK-4117 in Japanese Subjects With Perennial Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-20","primaryCompletion":"2014-01-26","completion":"2014-01-26","firstPosted":"2013-08-07","resultsPosted":"2014-08-15","lastUpdate":"2024-06-18"},"enrollment":608,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Desloratadine 5 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Desloratadine 5 mg","type":"EXPERIMENTAL"},{"label":"Desloratadine 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a study to evaluate the efficacy and safety of desloratadine (MK-4117) in Japanese participants with perennial allergic rhinitis. The primary hypothesis is that desloratadine is superior to placebo after 2 weeks of treatment with regard to change from baseline in Total Nasal Symptom Score among Japanese participants with perennial allergic rhinitis.","primaryOutcome":{"measure":"Change From Baseline in Total Nasal Symptom Score (TNSS) Assessed by the Investigator at Week 2","timeFrame":"Baseline and Week 2","effectByArm":[{"arm":"Desloratadine 5 mg","deltaMin":-1.96,"sd":2.21},{"arm":"Desloratadine 10 mg","deltaMin":-1.94,"sd":2.21},{"arm":"Placebo","deltaMin":-1.87,"sd":2.34}],"pValues":[{"comp":"OG000 vs OG002","p":"0.661"},{"comp":"OG001 vs OG002","p":"0.707"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":202},"commonTop":["Nasphopharyngitis"]}}